companydata.dkcompanydata.dk

PHARMADVICE ApS: Financial statements 2024

CVR: 26527651

Source: annual report 2024, Danish Business Authority

01/01/202431/12/2024

PHARMADVICE ApS (CVR 26527651) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 6,719,182 and a net result of DKK 658,935 compared with DKK 608,525 the year before. That is an increase of 13.1% compared with the year before. Equity in the 2024 report amounted to DKK 1,498,756. The solvency ratio was 70.2%. The company had 7 employees in the financial year.

Gross Profit
DKK 6,719,182
Profit/Loss
DKK 658,935
Equity
DKK 1,498,756
Total Assets
DKK 2,135,321
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-6.7 mio.659 t.1.5 mio.7
2023-5.9 mio.609 t.1.4 mio.6
2022-5.3 mio.717 t.1.5 mio.6
2021-3.9 mio.276 t.839 t.5
2020-4.2 mio.309 t.1 mio.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

PHARMADVICE ApS: The 2023 annual report is outMay 25, 2024

PHARMADVICE ApS has published its annual report for 2023. Gross profit came to DKK 5,940,070, and the net result was DKK 608,525.

About PHARMADVICE ApS

PHARMADVICE ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2002. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Susanne Ølsgaard Felumb. The company is owned by Felumb Holding ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 6,375,693 and a net result of DKK 503,512 compared with DKK 658,935 the year before. Equity in the 2025 report amounted to DKK 1,402,268.

Source: annual report 2025, Danish Business Authority